Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Tybourne Capital Management

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 15
Average round size
info
The average size of a deal this fund participated in
$69M
Portfolio companies 11
Rounds per year 1.50
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.27
Exits 3
Key employees Soon
Stages of investment
Late Stage Venture
Private Equity

Areas of investment

  • Biotechnology
  • E-Commerce
  • Payments
  • Finance
  • FinTech
Summary

The leading representative office of defined VC is situated in the Hong Kong. The company was established in Asia in Hong Kong.

Deals in the range of 50 - 100 millions dollars are the general things for fund. The top activity for fund was in 2019. The fund is constantly included in 2-6 deals per year.

The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Tybourne Capital Management, startups are often financed by Kairos Ventures, Visa, Sumitomo Mitsui Trust Bank. The meaningful sponsors for the fund in investment in the same round are Temasek Holdings, Spruce Capital Partners, Soros Capital Management.

Among the various public portfolio startups of the fund, we may underline Paidy, Provivi The fund has no specific favorite in a number of founders of portfolio startups. Among the most successful fund investment fields, there are Agriculture, FinTech. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is no match between the location of its establishment and the land of its numerous investments - Japan.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Tybourne Capital Management:
Typical Co-investors
Tybourne Capital Management is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Tybourne Capital Management:

Funds with similar focus

Funds from China
Funds with similar focus located in China:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
1982 Ventures -
Audible New Jersey, Newark, United States
BCD Travel Netherlands, Utrecht, Utrecht
Brain Corp California, San Diego, United States
Fashion 22 -
Global Alliance for Genomics & Health Canada, Ontario, Toronto
Jane VC Boston, Massachusetts, United States
Metropolitan Venture Partners New York, New York, United States
MIA Investment Limited Dorset, Poole, United Kingdom
Optimist Capital -
Saiyi Industry Fund -
SeedersClub Bangkok, Krung Thep, Thailand
SG Gestion France, Ile-de-France, Paris
Technology Development Fund Gullbringusysla, Iceland, Reykjavík
The Grosvenor Funds District of Columbia, United States, Washington
Total Sport and Entertainment Australia, Crows Nest, Queensland
U.S. Department of Energy Advanced Manufacturing Office District of Columbia, United States, Washington
VANTEC Angel Network British Columbia, Canada, Vancouver
Wadhawan Global Capital India, Maharashtra, Mumbai

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

CADDi

Manufacturing
$72M23 Aug 2021 Chiyoda, Japan

Zentera Therapeutics

Biotechnology
Pharmaceutical
$75M04 Aug 2021 Shanghai, Shanghai, China

Agriculture
Biotechnology
Chemical
$45M22 Dec 2020 Santa Monica, California, United States

Zentera Therapeutics

Biotechnology
Pharmaceutical
$20M21 May 2020 Shanghai, Shanghai, China

Paidy

Finance
Financial Services
FinTech
Payments
$83M01 Nov 2019 Chiba Prefecture

Agriculture
Biotechnology
Chemical
$85M15 Oct 2019 Santa Monica, California, United States

CarDekho

Automotive
E-Commerce
Information Services
Information Technology
Software
$110M03 Jan 2019 Gurugram, Haryana, India

Bicycle Therapeutics

Biotechnology
Medical Device
Therapeutics
$27M01 Dec 2018 England

FreeCharge

Coupons
E-Commerce
Internet
Payments
$80M05 Feb 2015 India, Maharashtra
News
Japan’s B2B ordering and supply platform CADDi raises $73 million Series B funding

– CADDi, a B2B ordering and supply platform in the manufacturing and procurement industry, raised $73m in Series B funding.
– The round was led by Globis Capital Partners and World Innovation Lab (WiL), with participation from existing investors DCM and Global Brain.
– Six new investors also joined the round including Arena Holdings, DST Global, Minerva Growth Partners, Tybourne Capital Management, JAFCO Group and SBI Investment.
– The post-money valuation is estimated at $450m.
– The funding proceeds will be used for accelerating digital transformation of the platform, hiring and expanding to global markets.

Zentera Therapeutics Raises $75M in Series b Funding

– Zentera Therapeutics, a Shanghai, China-based clinical-stage biopharmaceutical company, raised $75M in Series B funding.
– The round was led by OrbiMed Advisors Asia and Tybourne Capital Management with participation from Avidity Partners, Casdin Capital, Surveyor Capital, Farallon Capital Management, Lilly Asia Ventures, Logos Capital, Perceptive Advisors, Redmile Group and Viking Global Investors.
– The company intends to use the funds to advance the development of three Zentalis-discovered oncology clinical candidates as well as business development for future pipeline additions in China.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Tybourne Capital Management?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 15
Average round size 69M
Rounds per year 1.50
Peak activity year 2021
Lead investments 1
Follow on index 0.27
Exits 3
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

CADDi

Manufacturing
$72M23 Aug 2021 Chiyoda, Japan

Zentera Therapeutics

Biotechnology
Pharmaceutical
$75M04 Aug 2021 Shanghai, Shanghai, China

Agriculture
Biotechnology
Chemical
$45M22 Dec 2020 Santa Monica, California, United States

Zentera Therapeutics

Biotechnology
Pharmaceutical
$20M21 May 2020 Shanghai, Shanghai, China

Paidy

Finance
Financial Services
FinTech
Payments
$83M01 Nov 2019 Chiba Prefecture

Agriculture
Biotechnology
Chemical
$85M15 Oct 2019 Santa Monica, California, United States

CarDekho

Automotive
E-Commerce
Information Services
Information Technology
Software
$110M03 Jan 2019 Gurugram, Haryana, India

Bicycle Therapeutics

Biotechnology
Medical Device
Therapeutics
$27M01 Dec 2018 England

FreeCharge

Coupons
E-Commerce
Internet
Payments
$80M05 Feb 2015 India, Maharashtra
Crunchbase icon

Content report

The following text will be sent to our editors: